Intrinsic Value of S&P & Nasdaq Contact Us

Verona Pharma plc VRNA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • GB • USD

SharesGrow Score
33/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$107.00
+0.1%

Verona Pharma plc (VRNA) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, AKRO, AMLX, APLS, DAWN, IDYA and others.

VRNA has a market capitalization of $72.68B, compared to an average peer market cap of $3.4B. VRNA is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message